<qa>  What was the purpose of the Phase 3 multicenter trial?This was a Phase 3, multicenter, randomized, double-blind, placebo-controlled trial designed to evaluate the efficacy and safety of adalimumab ADA in patients with moderately to severely active ulcerative colitis UC. 